We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Actinogen Medical Limited is a biotechnology business based in Australia. Actinogen Medical shares (ACW) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Actinogen Medical has a trailing 12-month revenue of around $2 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.019 - $0.195 |
|---|---|
| 50-day moving average | $0.0942 |
| 200-day moving average | $0.0838 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.003 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.099
| 1 week (2021-09-13) | 10.00% |
|---|---|
| 1 month (2021-08-20) | 26.92% |
| 3 months (2021-06-21) | -36.13% |
| 6 months (2021-03-19) | 219.35% |
| 1 year (2020-09-18) | 253.57% |
|---|---|
| 2 years (2019-09-20) | 1,137.50% |
| 3 years (2018-09-20) | 90.38% |
| 5 years (2016-09-20) | 67.80% |
| Revenue TTM | $2 million |
|---|---|
| Gross profit TTM | $2 million |
| Return on assets TTM | -16.16% |
| Return on equity TTM | -27.62% |
| Profit margin | -197.32% |
| Book value | 0.011 |
| Market capitalisation | $166.1 million |
TTM: trailing 12 months
We're not expecting Actinogen Medical to pay a dividend over the next 12 months.
Actinogen Medical's shares were split on a 1:2 basis on 2 December 2013. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Actinogen Medical shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Actinogen Medical shares which in turn could have impacted Actinogen Medical's share price.
Over the last 12 months, Actinogen Medical's shares have ranged in value from as little as $0.019 up to $0.195. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Actinogen Medical's is 2.4128. This would suggest that Actinogen Medical's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic neurological diseases in Australia. The company is developing Xanamem, a therapy for Alzheimer's disease, and cognitive impairment associated with schizophrenia, diabetes, and other disorders; and XanADu, which has completed Phase II clinical trials is a double-blind, randomized, and placebo-controlled study to assess the safety, tolerability, and efficacy of Xanamem in subjects with mild Alzheimer's disease. It is also developing XanaHES, a single blinded, central reader blinded, placebo-controlled, and dose escalation study of Xanamem to assess safety and tolerability in healthy elderly subjects. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is headquartered in Sydney, Australia.
Shares in the telecoms operator have jumped nearly 40% over the last 12 months.
This guide will show you step-by-step instructions on how to buy the IRON Titanium Token (TITAN) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Wabi (WABI) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Cindicator (CND) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the MonaCoin (MONA) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Bluzelle (BLZ) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Whitecoin (XWC) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Storj (STORJ) token as well as a list of exchanges you can trade it on.
Despite the good news, Qantas shares closed flat following the announcement, but that could change in the coming weeks.
Shares in the lithium producer are up five-fold over the last 12 months.
